Calpastatin (the Endogenous Calpain Inhibitor) and Membrane Protein Degradation in Cell Fusion

  • Nechama S. Kosower
  • Sivia Barnoy
Part of the Methods in Molecular Biology™ book series (MIMB, volume 144)


Cell membrane fusion is a ubiquitous cellular process, mediating such phenomena as fertilization, muscle development, certain viral infections, and giant cell formation from macrophages. For membrane fusion to occur, the cell membranes must attach to each other, usually by means of interactions between membrane receptors. Increased cellular Ca2+ is required for the various fusion events, and changes occur in the cell membrane and cytoskeleton. Fusion of membranes occurs between the two phospholipid bilayers in regions that are poor in proteins (fusion-potent domains). It has been proposed that membrane protein degradation contributes to the disorganization of cell membrane and cytoskeleton in preparation for the fusion of the cell membranes (1, 2, 3).


Cysteine Protease Inhibitor Erythrocyte Suspension Erythrocyte Ghost Myoblast Differentiation Myoblast Fusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Yanagimachi R. (1988) Sperm-egg fusion. Curr. Top. Membr. Transp. 32, 3–43.Google Scholar
  2. 2.
    Wakelam M. J. O. (1988) Myoblast fusion: a mechanistic analysis. Curr. Top.Membr. Transp. 32, 87–112.Google Scholar
  3. 3.
    Okada Y. (1988) Sendai virus-mediated cell fusion. Curr. Top. Membr. Transp.32, 297–336.Google Scholar
  4. 4.
    Murachi T. (1984) Calcium-dependent proteinase and specific inhibitors: Calpain and calpastatin. Biochem. Soc. Symp. 49, 149–167.PubMedGoogle Scholar
  5. 5.
    Ahkong Q. F., Fisher D., Tampion W., and Lucy J. A. (1975) Mechanisms of cell fusion. Nature 253, 194–195.PubMedCrossRefGoogle Scholar
  6. 6.
    Kosower E. M., Kosower N. S., and Wegman P. (1977) Membrane Mobility agents. V: The mechanism of particle-cell and cell-cell fusion. Biochim. Biophys. Acta 471, 311–329.PubMedCrossRefGoogle Scholar
  7. 7.
    Kosower N. S., Glaser T., and Kosower E. M. (1983) Membrane-mobility agent-promoted fusion of erythrocyte: Fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins. Proc. Natl. Acad. Sci. U.S.A. 80, 7542–7546.PubMedCrossRefGoogle Scholar
  8. 8.
    Kosower N. S. and Glaser T. (1990) The calpain-calpastatin system and membrane fusion, in Intracellular Calcium-Dependent Proteolysis (Mellgren R. L. and Murachi T., eds.) CRC Press Boca Raton, FL. pp. 163–180.Google Scholar
  9. 9.
    Barnoy S., Glaser T., and Kosower N.S. (1996) The role of calpastatin (the specifc calpain inhibitor) in myoblast differentiation and fusion. Biochem. Biophys. Res. Commun. 220, 933–938.PubMedCrossRefGoogle Scholar
  10. 10.
    Barnoy S., Glaser T., and Kosower N. S. (1997) Calpain and calpastatin in myoblast differentiation and fusion: Effects of inhibitors. Biochim. Biophys. Acta 1358, 181–188.PubMedCrossRefGoogle Scholar
  11. 11.
    Barnoy S., Glaser T., and Kosower N. S. (1998) The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochim. Biophys. Acta 1402, 52–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Raser K. J., Posner A., and Wang K. K. W. (1995) Casein zymography: A method to study μ-calpain, m-calpain and their inhibitory agents. Arch. Biochem. Biophys. 319, 211–216.PubMedCrossRefGoogle Scholar
  13. 13.
    Hayashi M., Saito Y., and Kawashima S. (1992) Calpain activation is essential for membrane fusion of erythrocytes in the presence of exogenous Ca2+. Biochem. Biophys. Res. Commun. 182, 939–946.PubMedCrossRefGoogle Scholar
  14. 14.
    Ross E. and Schatz G. (1973) Assay of protein in the presence of high concentrations of sulfhydryl compounds. Anal. Biochem. 54, 304–306.PubMedCrossRefGoogle Scholar
  15. 15.
    Massague J., Cheifetz S., Endo T., and Nadal-Ginard B. (1986) Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl.Acad. Sci. U.S.A. 83, 8206–8210.PubMedCrossRefGoogle Scholar
  16. 16.
    Schwarz-Benmeir N., Glaser T., Barnoy S., and Kosower N.S. (1994) Calpastatin in erythrocytes of young and old individuals. Biochem. J. 304, 365–370.PubMedGoogle Scholar
  17. 17.
    Glaser T. and Kosower N.S. (1986) Calpain-calpastatin and fusion: Fusibility of erythrocytes is determined by a protease-protease inhibitor (calpain-calpastatin) balance FEBS Lett. 206, 115–120.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Nechama S. Kosower
    • 1
  • Sivia Barnoy
    • 1
  1. 1.Department of Human Genetics and Molecular Medicine, Sackler School of MedicineTel Aviv UniversityTel AvivIsrael

Personalised recommendations